entertainment -WSS

entertainment

author：hotspot 2025-09-05 11:31:41 - browse：4

An illustration of a human torso, through which the intestines, multicolored, are visible. — Adobe

We never walk alone. Across the landscape of our bodies, trillions of microbes accompany us on the journey of life, some of them riding it out in the body’s soft bits from first to dying breath.

A decade or so ago, the human microbiome was a revolutionary concept. Its unknown links to disease intrigued researchers across the globe. Now, some microbiome researchers are trying to usher in a new phase, in which modern tools and analytical approaches can show the connection between microbes and disease, and edge the field closer to potential treatments.

In the early days of this work, and still today, many findings were about correlations: a certain bug was found in a person with a specific illness. The effort now is to prove causation — which microbes could be directly responsible for the onset or progression of diseases. In the past week alone, three papers published in scientific journals have drawn links between microbiome residents and chronic diseases.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

WSS

Research misconduct: Proposed new rules face resistance

Research misconduct: Proposed new rules face resistance

Trump drops motion seeking removal of DA probing efforts to overturn 2020 election in Georgia

For BCIs, commercial hurdles may be bigger than scientific ones

eGenesis tests gene

Eli Lilly, Pfizer, and others want in on the online prescription market

focus

entertainment

focus

Heart attack and stroke risk calculators need revising

Wild otter attack leads to woman being airlifted to hospital, 2 others treated for injuries

Heart attack and stroke risk calculators need revising

The surgeon had a dilemma only a Nazi medical text could resolve

BioMarin wins approval for gene therapy to treat hemophilia A

AI generated plenty of interest at JPM but not a lot of trust

Apple is now the first public company to be valued at $3 trillion

Attacks on the drug industry will lead to fewer breakthroughs

Supreme Court strikes down use of affirmative action

EU regulator recommends expanding Mounjaro approval to obesity

leisure time

Gilead’s Trodelvy fails in lung cancer, raises questions on ADCs

Prior authorization will have to move faster under new Biden rule

Humana, CVS hope to turn members into patients at clinics

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

'Ancient DNA,' 23andMe reveal African American ancestries

OTC birth control: A brief history of over the counter pill design

entertainment

leisure time

explore

hotspot